PKM2 and LDHA seem to synergistically catalyze the glycolytic process to promote oncogenic metabolic reprogramming and appear to play a crucial role during the initiation and progression of pancreatic cancer [32,33,34]. The gene discussed is PKM; the disease is familial pancreatic carcinoma.